H.R. 1548: Pathway for Biosimilars Act
H.R. 1548: Pathway for Biosimilars Act
A bill in the U.S. Congress: To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes.
Results for bill H.R. 1548: Pathway for Biosimilars Act
No media matches
- Sponsor: Anna G. Eshoo
- Introduced: Mar 17, 2009
- Bill Profile on Open Congress
- Bill Funding Profile on MAPLight
Cosponsors
- Cosponsor: Timothy H. Bishop, Pete Sessions, Fred Upton, Baron Hill, Judy Biggert, Mark Green, James P. McGovern, Tim Holden, William D. Delahunt, Greg Walden, Chris Carney, Heath Shuler, Mike Thompson, Charlie Melancon, Mark E. Souder, Mike Rogers, Gregory W. Meeks, Kevin McCarthy, Randy Neugebauer, Allyson Y. Schwartz, Devin Nunes, Ileana Ros-Lehtinen, Michael E. Capuano, Adam Smith, Ralph M. Hall, Darrell E. Issa, Wally Herger, Joe Barton, Thaddeus G. McCotter, Jason Altmire, Edolphus Towns, Ellen O. Tauscher, Joe Wilson, Rush D. Holt, Chaka Fattah, Stephen F. Lynch, Zoe Lofgren, John Sullivan, Sam Johnson, Charles W. Dent, Jim Gerlach, Loretta Sanchez, Joe Courtney, Joe Donnelly, Melissa L. Bean, Joseph Crowley, Mary Bono, David Dreier, Brian Bilbray, Tammy Baldwin, Steven Kagen, Joseph R. Pitts, Chet Edwards, John Barrow, Jay Inslee, David E. Price, Richard E. Neal, Thomas E. Petri, Michael M. Honda, Robert A. Brady, Paul Hodes, Susan A. Davis, Mike Pence
